Ignatiusrielly, I suspect Anavex’s name was intentionally left out of the article for legal purposes. They wouldn’t want to be accused of “pumping “ the stock with a paid promotion at this stage of regulatory approval in the EU and possibly upcoming FDA submission.
Market Data 
Markets 
AI
